hm95573
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2015 (NCT02405065)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hm95573
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04835805 | Phase 1 | May 13, 2021 | Genentech, Roche |
| NCT03284502 | Phase 1 | May 22, 2017 | Hanmi Pharmaceutical |
| NCT03118817 | Phase 1 | Apr 1, 2017 | Hanmi Pharmaceutical |
| NCT02405065 | Phase 1 | Jan 1, 2015 | Hanmi Pharmaceutical |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hanmi Pharmaceutical | For profit | 3 | 3 | 1 | 2015 |
| Genentech | For profit | 1 | 1 | 1 | 2021 |
| Roche | For profit | 1 | 0 | 1 | 2021 |
3 organizations
Page 1 / 1